Clinical Trial Update: Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia [Phase 2]

View source ↗

Summary

This clinical trial update notes a Phase II study of asciminib as second-line treatment for chronic phase chronic myeloid leukemia, and the trial is currently r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• SCEMBLIX (ASCIMINIB)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Malignant Solid Tumors | Phase 2 | Status: RECRUITING